Find clinical trials for Lymphoma in Montréal, QC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Montréal, QC, CAN:
patients diagnosed with advanced Relapsed/Refractory non-Hodgkin's lymphoma to determine if ARV-393 may be a possible treatment option.ARV-3...
Phase 1
Montreal, Quebec, Canada and 13 other locations
pharmacokinetics and pharmacodynamics of IKS03, a CD19 targeting antibody-drug conjugate, in patients with advanced B cell non-Hodgkin lymphoma...
Phase 1
Montréal, Quebec, Canada and 12 other locations
TrAVeRse is a multicentre, open-label, Phase II study of AVR in treatment naïve MCL participants. The primary objective will be to assess the rate of...
Phase 2
Montreal, Quebec, Canada and 28 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Montreal, Quebec, Canada and 215 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Montréal, Quebec, Canada and 93 other locations
This is a global, randomised, Phase III, multicentre, open-label study evaluating the efficacy, safety and the degree of added benefit of the AZD0486...
Phase 3
Montreal, Quebec, Canada and 43 other locations
The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemoth...
Phase 3
Montréal, Canada and 143 other locations
This is a phase I dose-escalation study of oral PCLX-001, conducted in a multicenter, non-randomized, open-label, non-controlled design. The study is...
Phase 1
Montréal, Quebec, Canada and 3 other locations
This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...
Phase 2
Montreal, Quebec, Canada and 56 other locations
safety, and tolerability BGB-3111 plus obinutuzumab versus obinutuzumab alone in participants with relapsed/refractory non-Hodgkin follicular lymphoma...
Phase 2
Montreal, Quebec, Canada and 83 other locations
Clinical trials
Research sites
Resources
Legal